Comment: In Partners case, DOJ lets Massachusetts take lead role
By Leah Nylen ( November 17, 2014, 14:55 GMT | Comment) -- In the Partners Healthcare case, the US Department of Justice is in the unusual position of standing on the sidelines while Massachusetts pursues a controversial conduct remedy related to the proposed mergers. DOJ’s posture in the case — it supports the Massachusetts attorney general but hasn’t signed on to the deal or closed its own investigation — is likely the result of several factors, including the federal antitrust agencies’ general opposition to conduct remedies and the particular regulatory situation of healthcare in Massachusetts.In the Partners Healthcare case, the US Department of Justice is in the unusual position of standing on the sidelines while Massachusetts pursues a controversial conduct remedy related to the proposed mergers. DOJ’s posture in the case — it supports the Massachusetts attorney general but hasn’t signed onto the deal or closed its own investigation — is likely the result of several factors including the federal antitrust agencies’ general opposition to conduct remedies and the particular regulatory situation of healthcare in Massachusetts....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline